Investor

GLIN Impact Capital

Independent VC Domestic (Japan)

2026 activity

Amounts are the full announced figure. Grey amounts aren't counted in equity totals. † includes debt, grants or other non-equity (hover for detail).

DateCompanyStageAmountInvestorsSector
25 Sept 2026 MTMetagen Therapeutics Series B extension ¥300M GLIN Impact Capital BiotechDeep tech